About
ProVerum is an Irish medical device company founded in 2016, originating from Trinity College Dublin. The company focuses on developing minimally invasive treatment solutions for benign prostatic hyperplasia (BPH), a condition that affects many men and causes lower urinary tract symptoms. The flagship product, the ProVee® System, features a nitinol stent designed to reshape the enlarged prostate. This device is delivered through a flexible, steerable system with integrated imaging, allowing procedures to be performed safely in a doctor's office under local anesthesia. This approach offers a less invasive alternative to traditional surgeries, aiming to reduce procedural time, side effects, and the risk of re-hospitalization. ProVerum's technology enhances care pathways for doctors and provides cost savings for healthcare systems by minimizing the need for surgery and its associated complications. The company has secured significant investment, including an $80 million Series B financing round in 2025, to support its clinical programs and prepare for commercialization in Europe and the US.
Technologies
Keywords
Company Information
- Employees26
- Founded2014
- Total Funding$118154818
Location
16 Trinity Street, Dublin, County Dublin, Ireland, 2
